![](https://ml.globenewswire.com/media/f76bdad8-1e5c-4347-a892-647b49727178/small/anvs-logo-jpg.jpg)
Annovis Bio Reports Second Quarter Financial Results and Provides Business Update
MALVERN, Pa., Aug. 15, 2024 (GLOBE NEWSWIRE) -- via IBN -- Annovis Bio Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a clinical-stage drug platform company developing novel therapies for neurodegenerative diseases such as Alzheimer’s disease (AD) and …